Jingsong Zhou

Prof. Dr. Jingsong Zhou

Department of Kinesiology, University of Texas at Arlington, TX 76010, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2015 in Physiological Reports
Verified
Journal Article
Open access
PDF file
SWShaoping Wu
Shaoping Wu
JYJianxun Yi
Jianxun Yi
YZYong-Guo Zhang
Yong-Guo Zhang
Jingsong ZhouJingsong Zhou
Jingsong Zhou
JSJun Sun
Jun Sun
Emerging evidence has demonstrated that intestinal homeostasis and the microbiome play essential roles in neurological diseases, such as Parkinson's disease. Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by a progressive loss of motor neurons and muscle atrophy. Currently, there is no effective treatment. Most patients die within 3–5 years due to respiratory paralysis. Although the death of motor neurons is a hallmark of ALS, other organs may also contribute to the disease progression. We examined the gut of an ALS mouse model, G93A, which expresses mutant superoxide dismutase (SOD1G93A), and discovered a damaged tight junction structure and increased permeability with a significant reduction in the expression levels of tight junction protein ZO‐1 and the adherens junction protein E‐cadherin. Furthermore, our data demonstrated increased numbers of abnormal Paneth cells in the intestine of G93A mice. Paneth cells are specialized intestinal epithelial cells that can sense microbes and secrete antimicrobial peptides, thus playing key roles in host innate immune responses and shaping the gut microbiome. A decreased level of the antimicrobial peptides defensin 5 alpha was indeed found in the ALS intestine. These changes were associated with a shifted profile of the intestinal microbiome, including reduced levels of Butyrivibrio Fibrisolvens, Escherichia coli, and Fermicus, in G93A mice. The relative abundance of bacteria was shifted in G93A mice compared to wild‐type mice. Principal coordinate analysis indicated a difference in fecal microbial communities between ALS and wild‐type mice. Taken together, our study suggests a potential novel role of the intestinal epithelium and microbiome in the progression of ALS.

29 November 2017 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
KCKen Chen
Ken Chen
ZXZaicheng Xu
Zaicheng Xu
YLYukai Liu
Yukai Liu
ZWZhen Wang
Zhen Wang
YLYu Li
Yu Li
CZChunyu Zeng
Chunyu Zeng
Irisin protects against ischemia/reperfusion injury to the lung by improving mitochondrial function.

1 December 2018 in Pharmacological Research
Verified
Journal Article
Closed access
YXYajuan Xiao
Yajuan Xiao
CKChehade Karam
Chehade Karam
JYJianxun Yi
Jianxun Yi
LZLin Zhang
Lin Zhang
XLXuejun Li
Xuejun Li
Jingsong ZhouJingsong Zhou
Jingsong Zhou

11 October 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
ZBZehua Bian
Zehua Bian
QWQiang Wang
Qiang Wang
XZXinyu Zhou
Xinyu Zhou
TTTao Tan
Tao Tan
Ki Ho ParkKi Ho Park
Ki Ho Park
JMJianjie Ma
Jianjie Ma
MG53 is a muscle-specific TRIM-family protein that presides over the cell membrane repair response. Here, we show that MG53 present in blood circulation acts as a myokine to facilitate tissue injury-repair and regeneration. Transgenic mice with sustained elevation of MG53 in the bloodstream (tPA-MG53) have a healthier and longer life-span when compared with littermate wild type mice. The tPA-MG53 mice show normal glucose handling and insulin signaling in skeletal muscle, and sustained elevation of MG53 in the bloodstream does not have a deleterious impact on db/db mice. More importantly, the tPA-MG53 mice display remarkable dermal wound healing capacity, enhanced muscle performance, and improved injury-repair and regeneration. Recombinant human MG53 protein protects against eccentric contraction-induced acute and chronic muscle injury in mice. Our findings highlight the myokine function of MG53 in tissue protection and present MG53 as an attractive biological reagent for regenerative medicine without interference with glucose handling in the body.

1 March 2019 in Archives of Biochemistry and Biophysics
Verified
Journal Article
Closed access
Jingsong ZhouJingsong Zhou
Jingsong Zhou
ALAng Li
Ang Li
XLXuejun Li
Xuejun Li
JYJianxun Yi
Jianxun Yi

19 January 2015 in Physiological Reports
Verified
Journal Article
Open access
PDF file
YXYajuan Xiao
Yajuan Xiao
CMChangling Ma
Changling Ma
JYJianxun Yi
Jianxun Yi
SWShaoping Wu
Shaoping Wu
GLGuo Luo
Guo Luo
Jingsong ZhouJingsong Zhou
Jingsong Zhou
Accumulation of abnormal protein inclusions is implicated in motor neuron degeneration in amyotrophic lateral sclerosis (ALS). Autophagy, an intracellular process targeting misfolded proteins and damaged organelles for lysosomal degradation, plays crucial roles in survival and diseased conditions. Efforts were made to understand the role of autophagy in motor neuron degeneration and to target autophagy in motor neuron for ALS treatment. However, results were quite contradictory. Possible autophagy defects in other cell types may also complicate the results. Here, we examined autophagy activity in skeletal muscle of an ALS mouse model G93A. Through overexpression of a fluorescent protein LC3‐RFP, we found a basal increase in autophagosome formation in G93A muscle during disease progression when the mice were on a regular diet. As expected, an autophagy induction procedure (starvation plus colchicine) enhanced autophagy flux in skeletal muscle of normal mice. However, in response to the same autophagy induction procedure, G93A muscle showed significant reduction in the autophagy flux. Immunoblot analysis revealed that increased cleaved caspase‐3 associated with apoptosis was linked to the cleavage of several key proteins involved in autophagy, including Beclin‐1, which is an essential molecule connecting autophagy and apoptosis pathways. Taking together, we provide the evidence that the cytoprotective autophagy pathway is suppressed in G93A skeletal muscle and this suppression may link to the enhanced apoptosis during ALS progression. The abnormal autophagy activity in skeletal muscle likely contributes muscle degeneration and disease progression in ALS.